A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption [PDF]
Medicina, 2021 Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj +7 more sources
Generalized fixed drug eruption following Pfizer‐BioNtech COVID‐19 vaccination [PDF]
Clinical Case Reports, 2022 Fixed drug eruption is a cutaneous drug reaction which recurs at the same site when the individual is exposed to the causative drug, characterized by single or multiple round sharply demarcated erythematous‐to‐violaceous patches.
Soodeh Kabir +2 more
doaj +3 more sources
Fixed Drug Eruption Caused by Garenoxacin: A Case Report and Literature Review. [PDF]
Cureus, 2023 A new quinolone antibiotic called garenoxacin was developed in Japan. Garenoxacin is known to produce cutaneous adverse effects, particularly fixed drug eruption in Japan, despite several reports of cutaneous adverse events in English-language literature.
Hara N, Saito-Sasaki N, Sawada Y.
europepmc +2 more sources
Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis. [PDF]
Front Med (Lausanne), 2023 Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without ...
Paulmann M +3 more
europepmc +2 more sources
Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review. [PDF]
Case Rep Dermatol Med, 2023 Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases.
Abtahi-Naeini B +4 more
europepmc +2 more sources
Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature. [PDF]
J Clin MedFixed drug eruption (FDE) is a well-recognized, non-immediate, drug hypersensitivity reaction, often attributed to the use of various medications, most commonly non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics.
Makris M +4 more
europepmc +2 more sources
Fixed drug eruption to erythromycin
Acta Dermato-Venereologica, 1984 A case of repeated eruption after administration of erythromycin is described. It is the first report of erythromycin as proven agent of such an allergic reaction.
Pigatto Pd +3 more
openalex +5 more sources
Hypopigmented penile fixed drug eruption [PDF]
Clinical Case Reports, 2022 Fixed drug eruptions (FDE) are typically associated with residual hyperpigmentation or non‐pigmenting lesions. There is no distinctive histopathological feature; though, drug provocation tests (DPT) can be confirmatory within 7 days.
Perpetua U. Ibekwe +5 more
doaj +2 more sources
Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting. [PDF]
Cureus, 2022 Fixed drug eruptions (FDEs) are dermatological manifestations of drug reactions that often occur in the same location upon re-exposure to a drug. They usually appear as erythematous-violaceous, circular patches, but several different variants have been ...
Shaker G, Mehendale T, De La Rosa C.
europepmc +2 more sources
Patch testing in fixed drug eruptions: a 20-year review. [PDF]
, 2011 BACKGROUND: The fixed drug eruption is a common adverse drug reaction. Clear identification of the culprit drug is not always possible in the clinical setting, and oral rechallenge may induce new lesions or severe reactions.
Andrade, P +2 more
core +3 more sources